Cite
HARVARD Citation
Serebruany, V. et al. (2015). Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?. Expert review of cardiovascular therapy. pp. 1333-1344. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Serebruany, V. et al. (2015). Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?. Expert review of cardiovascular therapy. pp. 1333-1344. [Online].